methylthio-adp has been researched along with adenosine in 15 studies
Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
146 | 2 | 43 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | methylthio-adp (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Boyer, JL; Brizzolara, AL; Burnstock, G; Fischer, B; Harden, TK; Hoyle, CH; Jacobson, KA; Knight, GE; Ziganshin, AU; Zimmet, J | 1 |
Azran, S; Danino, O; Dixit, M; Fischer, B; Förster, D; Kenigsberg, S; Major, DT; Reiser, G; Singh, V | 1 |
Colman, RF; Colman, RW; Freedman, MD; Grana, G; Hu, CJ; Mills, DC; Minniti, C; Puri, R | 1 |
Colman, RF; Colman, RW; Figures, WR; Mills, DC; Scearce, LM; Stewart, GJ | 1 |
Colman, RF; Colman, RW; Figures, WR; Mills, DC; Morinelli, TA; Niewiarowski, S | 1 |
Barnard, EA; Burnstock, G; King, BF; Simon, J; Webb, TE | 1 |
Duchêne, AD; Takeda, K | 1 |
Enkvist, E; Järv, J; Kelve, M; Raidaru, G; Sak, K; Subbi, J; Uri, A | 1 |
Claes, P; Grobben, B; Roymans, D; Slegers, H; Van Kolen, K | 1 |
Bagorda, A; Casavola, V; Di Sole, F; Favia, M; Guerra, L; Helmle-Kolb, C; Jacobson, KA; Reshkin, SJ | 1 |
Burnstock, G; Chiaravalli, AM; Frigo, G; Giaroni, C; Knight, GE; Lecchini, S; Zanetti, E | 1 |
Losavio, A; Muchnik, S; Veggetti, M | 1 |
Inoue, K; Kohsaka, S; Nakamura, Y; Ohsawa, K; Sanagi, T; Suzuki, E | 1 |
Baqi, Y; Hoffmann, K; Lutz, DA; Müller, CE; Straßburger, J; von Kügelgen, I | 1 |
Amaradasa, K; Bancroft, S; Dimofte, T; Hindle, MS; Hutchinson, JL; Johnson, T; Keith, M; Khalil, J; Mundell, SJ; Naseem, K; Roberts, T | 1 |
1 trial(s) available for methylthio-adp and adenosine
Article | Year |
---|---|
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Topics: Adenosine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adult; Binding Sites; Blood Platelets; Clopidogrel; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Purinergic; Thionucleotides; Thrombin; Ticlopidine | 1992 |
14 other study(ies) available for methylthio-adp and adenosine
Article | Year |
---|---|
Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
Topics: Adenine Nucleotides; Animals; Aorta; Colon; Enzyme Activation; Erythrocyte Membrane; Guinea Pigs; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth; Rabbits; Receptors, Purinergic P2; Structure-Activity Relationship; Sulfides; Turkeys; Type C Phospholipases; Vas Deferens | 1993 |
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.
Topics: Animals; Antioxidants; Cells, Cultured; Drug Discovery; Humans; Hydrogen Peroxide; Hydrolysis; Iron; Models, Molecular; Neurons; Neuroprotective Agents; Nucleosides; Nucleotides; PC12 Cells; Phosphorothioate Oligonucleotides; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y1 | 2015 |
Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Topics: Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Binding Sites; Blood Platelets; Cyclic AMP; Drug Synergism; Humans; Microscopy, Electron, Scanning; Thionucleotides | 1985 |
Identification of two distinct adenosine diphosphate receptors in human platelets.
Topics: Adenosine; Adenosine Diphosphate; Blood Platelets; Chymotrypsin; Cyclic AMP; Fibrinogen; Humans; In Vitro Techniques; Platelet Aggregation; Receptors, Cell Surface; Receptors, Purinergic; Thionucleotides | 1980 |
Characterisation of a recombinant P2Y purinoceptor.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Affinity Labels; Animals; Brain; Cell Line; Electrophysiology; Inositol Phosphates; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Recombinant Proteins; Suramin; Thionucleotides; Triazines; Uridine Triphosphate; Xenopus | 1995 |
P2Y- and P2U-mediated increases in internal calcium in single bovine aortic endothelial cells in primary culture.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium; Cattle; Cells, Cultured; Ion Transport; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Thionucleotides; Uridine Triphosphate | 1997 |
Adenosine-derived non-phosphate antagonists for P2Y(1) purinoceptors.
Topics: Adenosine; Adenosine Diphosphate; Aspartic Acid; Astrocytoma; Dose-Response Relationship, Drug; Humans; Phosphates; Phosphatidylinositols; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Thionucleotides; Tumor Cells, Cultured | 2000 |
P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Division; Dinucleoside Phosphates; Enzyme Activation; Glioma; Hydrolysis; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Purinergic P2 Receptor Agonists; Pyridoxal Phosphate; Rats; Receptors, Purinergic P2; Thionucleotides; Time Factors; Triazines; Tumor Cells, Cultured | 2001 |
Extracellular adenine nucleotides regulate Na+/H+ exchanger NHE3 activity in A6-NHE3 transfectants by a cAMP/PKA-dependent mechanism.
Topics: Adenosine; Adenosine Diphosphate; Animals; Calcium; Cell Line; Cell Membrane; Cyclic AMP; Enzyme Inhibitors; Epithelial Cells; Hydrogen-Ion Concentration; Rats; Signal Transduction; Sodium-Hydrogen Exchangers; Thionucleotides; Transfection; Xenopus laevis | 2002 |
Postnatal development of P2 receptors in the murine gastrointestinal tract.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Dose-Response Relationship, Drug; Female; Gastrointestinal Tract; Gene Expression Regulation, Developmental; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thionucleotides; Uridine Triphosphate | 2006 |
Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.
Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine Diphosphate; Animals; Calcium; Electrophysiology; Exocytosis; Mice; Neuromuscular Junction; Purinergic P2 Receptor Agonists; Purines; Synaptic Transmission; Thionucleotides | 2008 |
Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine Deaminase Inhibitors; Adenosine Diphosphate; Animals; Animals, Newborn; Cell Movement; Cells, Cultured; Cerebral Cortex; Chemotaxis; Collagen; Flow Cytometry; Indicators and Reagents; JNK Mitogen-Activated Protein Kinases; Microglia; Purinergic P2Y Receptor Agonists; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Purinergic P2Y12; Thionucleotides | 2012 |
Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.
Topics: Adenosine; Adenosine Diphosphate; Animals; Binding Sites; Binding, Competitive; CHO Cells; Colforsin; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Mutation; Platelet Aggregation Inhibitors; Protein Binding; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Response Elements; Thionucleotides; Ticagrelor; Transfection | 2014 |
Ticagrelor inverse agonist activity at the P2Y
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Diphosphate; Blood Platelets; Diphosphates; Drug Inverse Agonism; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2024 |